Market Place
Sourcing Support
BlueSphere Bio Accepted as Member of Johnson & Johnson Innovation-JLABS
14 Aug 2024 //
GLOBENEWSWIRE
BlueSphere Bio Partners with NMDP for First-In-Human TCR-based Product Trial
25 Jun 2024 //
GLOBENEWSWIRE
BlueSphere Bio: NCI Collab For Rare Respiratory Disease Treatments
04 Jun 2024 //
GLOBENEWSWIRE
BlueSphere`s IND Cleared, New Cell Therapy For High-Risk Leukemias
03 Jun 2024 //
GLOBENEWSWIRE
BlueSphere To Present At BIO 2024 And Participate In Panel
30 May 2024 //
GLOBENEWSWIRE
BlueSphere Bio to Present at the Next Generation CAR & T Cell Therapies
01 Mar 2023 //
GLOBENEWSWIRE
BlueSphere Bio to Present at the 25th Annual BIO CEO & Investor Conference
06 Feb 2023 //
GLOBENEWSWIRE
BlueSphere Bio Appoints Erkut Bahceci, M.D., as Chief Medical Officer
30 Jan 2023 //
GLOBENEWSWIRE
BlueSphere Bio Presents Data Demonstrating the Potential of Product at (SITC)
10 Nov 2022 //
GLOBENEWSWIRE
BlueSphere Bio Data to be Presented at the 37th (SITC)
03 Nov 2022 //
GLOBENEWSWIRE
BlueSphere Bio Appoints Keir Loiacono as Chief Executive Officer
04 Oct 2022 //
GLOBENEWSWIRE
BlueSphere Bio Presents Data Demonstrating Efficiency of Parallel TCR Capture
26 Sep 2022 //
GLOBENEWSWIRE
BlueSphere Bio to Present at the 7th Annual CAR-TCR Summit
19 Sep 2022 //
GLOBENEWSWIRE
BlueSphere Bio to Present a Corporate Overview at the 2022 BIO
13 Jun 2022 //
GLOBENEWSWIRE
BlueSphere Bio Data to be Presented at the 2022 Joint ASTCT + EBMT
25 May 2022 //
GLOBENEWSWIRE
BlueSphere Bio Presents New Data Supporting TCXpress Platform at AACR
08 Apr 2022 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.